Manuel Hidalgo Medina

Oncologist, chief of the division of hematology and medical oncology at Weill Cornell Medicine/New York-Presbyterian Hospital and director at Bristol Myers Squibb1

Manuel Hidalgo Medina is an oncologist. He is director of the Leon V. and Marilyn L. Rosenberg Clinical Cancer Center at Beth Israel Deaconess Medical Center in Boston, Massachusetts, in the United States; he also heads its hematology/oncology division.2

From Wikipedia’s article on Manuel Hidalgo Medina (this version), CC BY-SA 4.0.

Born Jan 1, 1968.1

About

He specializes in pancreatic cancer. His research has included development of anti-cancer drugs such as erlotinib, nab-paclitaxel and temsirolimus, and the development of patient-derived tumor xenograft models.

From Wikipedia’s article on Manuel Hidalgo Medina, shared under CC BY-SA 4.0.2

Companies

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3